Potential mechanisms of Qili Qiangxin capsule to prevent pulmonary arterial hypertension based on network pharmacology analysis in a rat model

BACKGROUND: Qili Qiangxin capsule (QQC), a traditional Chinese medicine, has recently been approved to treat pulmonary arterial hypertension (PAH). However, the multi-target mechanism through which QQC acts on PAH has not been clarified. The objective of this study was to explore the pharmacological...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiao, Li, Chao, Yang, Ping, Jiang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096388/
https://www.ncbi.nlm.nih.gov/pubmed/35571420
http://dx.doi.org/10.21037/atm-22-901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096388/
https://www.ncbi.nlm.nih.gov/pubmed/35571420
http://dx.doi.org/10.21037/atm-22-901

Ejemplares similares